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Abstract: Diet and other lifestyle habits have been reported to contribute to the development of
dyslipidemia in various populations. Therefore, this study investigated the association between
dyslipidemia and dietary and other lifestyle practices among Saudi adults. Data were collected from
adults (≥20 years) not previously diagnosed with diabetes in a cross-sectional design. Demographic,
anthropometric, and clinical characteristics, as well as lifestyle and dietary habits were recorded
using a predesigned questionnaire. Fasting blood samples were drawn to estimate the serum lipid
profile. Out of 1385 people, 858 (62%) (491 men, 367 women) had dyslipidemia. After regression
analysis to adjust for age, body mass index, and waist circumference, an intake of ≥5 cups/week
of Turkish coffee, or carbonated drinks was associated with increased risk of dyslipidemia in men
(OR (95% CI), 2.74 (1.53, 4.89) p = 0.001, and 1.53 (1.04, 2.26) p = 0.03 respectively), while the same
intake of American coffee had a protective effect (0.53 (0.30, 0.92) p = 0.025). Sleep duration <6 h,
and smoking were also associated with increased risk in men (1.573 (1.14, 2.18) p = 0.006, and 1.41
(1.00, 1.99) p = 0.043 respectively). In women, an increased intake of fresh vegetables was associated
with increased risk (2.07 (1.09, 3.94) p = 0.026), which could be attributed to added salad dressing.
Thus, there are sex differences in response to dietary and lifestyle practices.
Keywords: dyslipidemia; serum cholesterol; serum triglycerides; serum low density lipoprotein;
serum high density lipoprotein; dietary intake; lifestyle
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1. Introduction
Cardiovascular diseases (CVD) are major health problems contributing to 31% of global death in
2017 according to the World Health Organization (WHO) [1]. The prevalence of CVD in Saudi Arabia
in 2004 has been reported to be 5.5% [2], accounting for almost 45.7% of deaths [3]. CVD has many
modifiable and non-modifiable risk factors, including certain diseases and disorders such as diabetes,
hypertension, and dyslipidemia, which commonly coexist in various populations [4–6]. Indeed,
dyslipidemia, defined as any abnormalities in serum lipids is considered atherogenic, and is reported
to be associated with an increased risk of ischemic heart disease [7,8]. Several studies have been
conducted to investigate the prevalence of dyslipidemia in Saudi Arabia in the past reporting an overall
prevalence of 20–54% [9–11]. A more recent study published in 2018 on people in the eastern region
of Saudi Arabia reported that the prevalence of (diagnosed and borderline) hypercholesterolemia,
hypertriglyceridemia, increased low-density lipoprotein (LDL-C)-cholesterol, and decreased high
density lipoprotein (HDL-C)-cholesterol were 51%, 26.9%, 38.1%, and 90.5%, respectively [12].
Many factors contribute to the development of dyslipidemia, including genetics, sex, ethnicity,
increased body mass index (BMI), dietary habits, and smoking [13]. In addition, changes in sleeping
patterns, and a short duration of sleep have also been associated with dyslipidemia [14]. Studies in
Saudi Arabia showed that age, sex, high BMI, and waist circumference (WC), smoking, low physical
activity, as well as intake of margarine were associated with dyslipidemia [10–12]. In spite of their
reported importance in controlling dyslipidemia and CVD [15,16], the association of dietary as well as
other lifestyle practices, including sleeping duration, with dyslipidemia were not fully investigated in
previous Saudi studies. Saudi Arabia is a very large country, with each region having its own dietary
and lifestyle characteristics. Therefore, we aimed to investigate such associations in more detail in
inhabitants of the city of Jeddah, the largest city in the western region, and the gateway to the two holy
cities of Islam, with a population of mixed ethnicities, bringing with them their own dietary habits.
We hope that our results will help in the formulation of evidence-based dietary and lifestyle guidelines
for people in our region to decrease the prevalence of dyslipidemia, which can be adopted in future,
more comprehensive programs for the prevention of CVD.
2. Materials and Methods
2.1. Study Design and Sample Collection
Presented data in this study were obtained between July 2016 and February 2017 from a
cross-sectional survey conducted in the city of Jeddah to develop a Saudi Dysglycemia Risk Score.
The Committee on the Ethics of Human Research at the Faculty of Medicine-King Abdulaziz University,
Jeddah approved the study (Reference No. 338-10). A full explanation of the sampling methodology
has been outlined in an earlier publication [17] and is summarized here as follows: adults (age ≥
20 years), not previously diagnosed with diabetes, were recruited from attendees of primary health
care centers (PHCC) in Jeddah, Saudi Arabia. An informed consent form was signed by consenting
volunteers. Demographic, dietary, and lifestyle variables, as well as medical history, and family history
of chronic diseases were collected from recruits using a predesigned questionnaire in the Arabic
language which was based on validated questionnaires used in previous risk score studies [18–22]
including an Arabic one [23]. The questionnaire was completed during a face to face interview by
trained medical students. Anthropometric and clinical measurements (weight, height, WC, and
blood pressure (BP)) were measured using standardized equipment and techniques as previously
explained [17]. Weight and fat percentage were measured using a portable calibrated scale (Omron
BF511; OMRON Healthcare, Kyoto, Japan). Weight and height were used to calculate BMI. A value
less than 18.5 indicates underweight, while a value of 18.5–<25 kg/m2 indicates healthy normal weight,
25–<30 indicates overweight, and ≥30 indicates obesity. Using WC to indicate abdominal adiposity the
first cut-off value for increased risk was defined as >94 cm for men, >80 cm for women, and the second
cut-off value as >102 cm for men, >88 cm for women [24,25].
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The section on dietary practices consisted of food frequency questions including 17 questions
covering intake of fruits, vegetables, red meat, whole grain bread/cereals, and various commonly
consumed beverages including fruit juices (fresh and otherwise), carbonated beverages, energy drinks,
different types of coffee such as Arabic, American, Turkish, and cappuccino, and various teas such as
red, green, cinnamon, and hibiscus tea. Participants were asked to specify whether they consumed
each item more than once daily, once daily, 5–6 portions per week, 1–4 portions per week, or not at all.
Food models representing portion sizes of relevant food items were presented to all participants to
help in making the correct decisions.
Fasting blood samples were taken, and serum was separated and stored at−80 ◦C for the estimation
of the lipid profile. A flow chart outlining steps in data collection is presented in Supplementary
Figure S1.
2.2. Biochemical Assays
Serum samples were sent regularly every 10 to 12 weeks to a collaborating laboratory at the
National Guard Hospital in Jeddah which is accredited by the College of American Pathologist.
Total cholesterol (TC), HDL-C and triglycerides (TG) levels were measured by spectrophotometric
methods using Architect c8000 auto-analyzer (Abbott Park, IL, USA). LDL-C was calculated using the
Friedewald equation [26].
2.3. Diagnosis of Dyslipidemia
Dyslipidemia was defined as LDL-C ≥ 3.37 mmol/L, HDL-C < 1.04 mmol/L for men and
< 1.3 mmol/L for women, TC ≥ 5.18 mmol/L, TG ≥ 1.7 mmol/L or treatment with lipid-lowering drugs
with all lipid levels in the normal range [27,28].
2.4. Statistical Analysis
IBM SPSS statistics version 20.0 for Windows was used to enter and analyze collected data.
The baseline characteristics of the study population were calculated statistically and described as mean,
standard deviations (SD), and frequencies.
Demographic, lifestyle, and clinical factors of people with high levels of TC, LDL-C, and TG,
and/or low level of HDL-C, as well as dyslipidemia in general, were analyzed by comparing to those
with normal lipid levels. Factors with continuous variables were analyzed using an independent t-test
to compare two groups, while those with categorical variables were analyzed using the Chi-square
test or Fisher’s exact test, as appropriate. Unadjusted and adjusted logistic regression models were
used for assessing the association between demographic, lifestyle, and dietary variables, and outcome
variables: specific and general types of dyslipidemia. Stepwise regression analysis was performed to
determine the dietary factors that had an influence on dyslipidemia. Independent factors included age,
BMI, and WC. Only related independent variables, where p < 0.15 after an initial logistic regression
between the dependent and independent variable was used in the corresponding stepwise regression
model to avoid excluding important covariates from the final model and to include predictors that
are serious or have high potential effect [29]. Values of p < 0.05 (two-sided test) were accepted as
statistically significant.
3. Results
A total of 1477 adults were recruited by the end of February 2017 (Supplementary Figure S1).
Complete data were obtained for 1385 people. Missing data were mainly due to missing, hemolysed,
broken, or unlabeled blood samples. This was completely random and is not expected to affect validity.
Following biochemical measurements, a total of 527 people (38%) (287 men, and 240 women) were
found to be normolipidemic, and 858 (62%) (491 men, and 367 women) had dyslipidemia. Thus,
there was no association between sex and dyslipidemia in general. The most prevalent type of
dyslipidemia was high LDL-C found in 567 people (40.9%) (341 men and 226 men), followed by high
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TC in 480 people (34.7%) (277 men and 203 women), and low HDL-C in 338 people (24.4%) (171 men
and 167 women) and the least prevalent type of dyslipidemia was high TG levels in 301 people (21.7%)
(218 men and 83 women). Therefore, increased LDL-C and TG were significantly more common in men
(p < 0.05 and p < 0.001 respectively) whereas low HDL-C was significantly more common in women
(p < 0.05).
3.1. Association between Dyslipidemia with Anthropometric Measurements
Demographic, clinical, and anthropometric characteristics of the study groups for men and
women are presented in Supplementary Table S1. There was a significant difference in demographic
and anthropometric measurements between the normolipidemic and dyslipidemic groups, with the
dyslipidemia group having a significantly higher means of age, BMI, weight, body fat percentage, neck,
waist and hip circumferences, and waist to hip and waist to height ratios (all p < 0.001, Supplementary
Table S1). In addition, men and women with dyslipidemia also had significantly higher means of
systolic and diastolic Bp and significantly higher means of TC, TG, LDL-C, and lower HDL-C compared
with people with normolipidemia (Supplementary Table S1). Comparing the distribution of various
characteristics between the normolipidemic and the dyslipidemic groups of men and women, age, BMI,
and WC were found to be significantly and directly associated with dyslipidemia (p < 0.001 at least,
Supplementary Table S2) and all its types (p < 0.015 at least, Supplementary Table S2). Dyslipidemia
was detected in 75% of participants over 30 years of age compared with 48.8% of those <30 years.
Moreover, dyslipidemia was present in 74.8% and 72% of obese men and women compared with
53.5% and 43.7% of normal weight and 29.2% and 32% underweight men and women respectively
(Supplementary Table S2a,b).
3.2. Patterns of Food Intake in Studied Men and Women
Recorded frequencies of the questionnaire were recategorized to no intake, 1–4 and 5 or more
portions per week due to small numbers in some categories. The difference in the recorded pattern of
food intake between men and women is shown in Table 1. Women reported eating more fresh and
cooked vegetables than men, whereas men had a higher intake of red meat (p < 0.001 at least, Table 1).
In addition, men reported drinking more fresh and non-fresh juice, soft drinks, energy drinks, red
tea, and American coffee compared with women (p < 0.01 at least, Table 1) whereas women reported
drinking more green tea, Arabic coffee, and cinnamon drink compared with men (p < 0.05 at least,
Table 1). There were no sex-differences in the consumption of fruits, whole grain products, Turkish
coffee, and hibiscus drink (Table 1).
The association between diet and dyslipidemia was analyzed in each sex group separately due to
the sex differences in both the prevalence of some types of dyslipidemia as well as food intake patterns.
3.2.1. Association between Food Intake and Dyslipidemia in Men
Comparing dietary habits in men between the two groups, a high intake of Turkish coffee was
significantly associated with dyslipidemia (p < 0.001, Table 2). On the other hand, people with a
moderate intake of 1–4 portions/week of American coffee had a lower prevalence of dyslipidemia
(p = 0.027, Table 2). Dyslipidemia was detected in 79% of people drinking five or more portions a
week Turkish coffee and in 65% of people who did not drink American coffee (Table 2). Turkish coffee
consumption was associated in particular with low HDL-C and high TC (p = 0.036 and p = 0.018,
respectively, Table 2). This association had a U-shape association as low HDL-C was detected in 22% in
people with no intake, in 15% of those with an intake of 1–4 portions per week and in 29% in those with
a weekly intake of five or more portions of Turkish coffee (Table 2). A similar U-shaped association
was found between American coffee consumption and TC (Table 2).
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Table 1. Food intake pattern by sex.
Men Women
χ2 (p-Value)
N (N%) N (N%)
Fruit (portion)
No intake 111 (14.0%) 72 (11.8%) 1.727
p = 0.4221–4/week 399 (50.4%) 323 (52.8%)
5 or more/week 281 (35.5%) 217 (35.5%)
Fresh vegetable (portion)
No intake 115 (14.5%) 53 (8.7%) 15.259
p < 0.0011–4/week 310 (39.2%) 225 (36.8%)
5 or more/week 366 (46.3%) 334 (54.6%)
Cooked vegetable (portion)
No intake 164 (20.7%) 67 (10.9%) 27.975
p < 0.0011–4/week 356 (45.0%) 278 (45.4%)
5 or more/week 271 (34.3%) 267 (43.6%)
Whole grains (portion)
No intake 113 (14.3%) 93 (15.2%) 3.187
p = 0.2031–4/week 146 (18.5%) 91 (14.9%)
5 or more/week 532 (67.3%) 428 (69.9%)
Red meat (portion)
No intake 58 (7.3%) 139 (22.7%) 77.64
p < 0.0011–4/week 453 (57.3%) 335 (54.7%)
5 or more/week 280 (35.4%) 138 (22.5%)
Fresh juice (portion)
No intake 182 (23.0%) 186 (30.4%) 10.039
p = 0.0071–4/week 412 (52.1%) 281 (45.9%)
5 or more/week 197 (24.9%) 145 (23.7%)
Non fresh juice (portion)
No intake 252 (31.9%) 259 (42.3%) 20.572
p < 0.0011–4/week 253 (32.0%) 191 (31.2%)
5 or more/week 286 (36.2%) 162 (26.5%)
Soft drinks (portion)
No intake 247 (31.2%) 298 (48.7%) 56.848
p < 0.0011–4/week 233 (29.5%) 175 (28.6%)
5 or more/week 311 (39.3%) 139 (22.7%)
Red tea (portion)
No intake 166 (21.0%) 182 (29.7%) 14.346
p = 0.0011–4/week 201 (25.4%) 133 (21.7%)
5 or more/week 424 (53.6%) 297 (48.5%)
Green tea (portion)
No intake 464 (58.7%) 323 (52.8%) 7.39
p = 0.0251–4/week 168 (21.2%) 130 (21.2%)
5 or more/week 159 (20.1%) 159 (26.0%)
Arabic coffee (portion)
No intake 347 (43.9%) 232 (37.9%) 10.33
p = 0.0061–4/week 214 (27.1%) 153 (25.0%)
5 or more/week 230 (29.1%) 227 (37.1%)
Turkish coffee (portion)
No intake 565 (71.4%) 440 (71.9%) 0.112
p = 0.9461–4/week 124 (15.7%) 92 (15.0%)
5 or more/week 102 (12.9%) 80 (13.1%)
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Table 1. Cont.
Men Women
χ2 (p-Value)
N (N%) N (N%)
American coffee (portion)
No intake 626 (79.1%) 531 (86.8%) 14.183
p = 0.0011–4/week 81 (10.2%) 43 (7.0%)
5 or more/week 84 (10.6%) 38 (6.2%)
Cappuccino (portion)
No intake 536 (67.8%) 368 (60.1%) 9.881
p = 0.0071–4/week 157 (19.8%) 139 (22.7%)
5 or more/week 98 (12.4%) 105 (17.2%)
Energy drinks (portion)
No intake 623 (78.8%) 545 (89.1%) 26.237
p < 0.0011–4/week 115 (14.5%) 45 (7.4%)
5 or more/week 53 (6.7%) 22 (3.6%)
Hibiscus drinks (portion)
No intake 719 (90.9%) 556 (90.8%) 0.57
p = 0.7521–4/week 58 (7.3%) 42 (6.9%)
5 or more/week 14 (1.8%) 14 (2.3%)
Cinnamon drink (portion)
No intake 707 (89.4%) 478 (78.1%) 37.241
p < 0.0011–4/week 52 (6.6%) 100 (16.3%)
5 or more/week 32 (4.0%) 34 (5.6%)
Data is shown as frequency and percentages of all people in the sex group. χ2 is the Chi-square test value followed
by its p-value. Significant differences between groups are shown in bold font.
After adjusting for age, BMI, and WC the weekly intake of five or more portions of Turkish coffee
was associated in men with a 2.77 increased odds for having dyslipidemia compared with those with
no intake (p < 0.001, Table 3), while a moderate and high intake of American coffee was associated with
0.55 and 0.55 decreased odds for having dyslipidemia compared with those with no intake (p = 0.037
and p = 0.031, respectively; Table 3). After performing the multivariable regression analysis for each
type of dyslipidemia separately and adjusting for age, BMI, and WC, there was no longer a significant
effect of Turkish coffee on any type; however, the effect of American coffee appeared only for moderate
consumption (1–4 portions/week) which was only significant for high TC (OR = 0.50; 95% CI: 0.27, 0.94;
p = 0.038) (data not shown).
There was no significant association between the consumption of carbonated drinks and
dyslipidemia when analyzed by Chi-square test. However, the regression analysis showed that
the weekly intake of five or more portions of carbonated drinks was associated with a 1.56 increased
odds for having dyslipidemia in general (but not specific types of dyslipidemia) in men compared
with those with no intake after adjusting for age, BMI, and WC (OR = 1.53 (CI: 1.04, 2.26) p = 0.03,
data not shown).
There was a U-shaped association between some other dietary variables and dyslipidemia when
analyzed by the Chi-square test. For example, fruits, fresh and cooked vegetables, and red tea
consumption had a U-shaped relationship with low HDL-C in men. However, these food types were
not predictors of dyslipidemia when analyzed using regression, adjusting for age and BMI (Table 3).
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Table 2. Comparison of dietary habits between normolipidemic and dyslipidemic men groups presented as number of men (%) for overall dyslipidemia, and
abnormalities in different lipid parameters.
Variable
General Dyslipidemia LDL-C HDL-C TC TG
No
(n = 287)
Yes
(n = 491)
Normal
(n = 437)
High
(n = 341)
Normal
(n = 607)
Low
(n = 171)
Normal
(n = 501)
High
(n = 277)
Normal
(n = 560)
High
(n = 218)
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Fruit (portion)
No intake 39 (35.8) 70 (64.2) 60 (55.0) 49 (45.0) 84 (77.1) 25 (22.9) 66 (60.6) 43 (39.4) 71 (65.1) 38 (34.9)
1–4/week 154 (39.1) 240 (60.9) 217 (55.1) 177 (44.9) 328 (83.2) 66 (16.8) 256 (65.0) 138 (35.0) 290 (73.6) 104 (26.4)
5 or more/week 94 (34.2) 181 (65.8) 160 (58.2) 115 (41.8) 195 (70.9) 80 (29.1) 179 (65.1) 96 (34.9) 199 (72.4) 76 (27.6)
X2 (p-value) 1.74 (p = 0.419) 0.7 (p = 0.705) 14.448 (p = 0.001) 0.818 (p = 0.664) 3.066 (p = 0.216)
Fresh vegetable (portion)
No intake 43 (37.7) 71 (62.3) 68 (59.6) 46 (40.4) 91 (79.8) 23 (20.2) 72 (63.2) 42 (36.8) 78 (68.4) 36 (31.6)
1–4/week 120 (39.3) 185 (60.7) 160 (52.5) 145 (47.5) 254 (83.3) 51 (16.7) 195 (63.9) 110 (36.1) 236 (77.4) 69 (22.6)
5 or more/week 124 (34.5) 235 (65.5) 209 (58.2) 150 (41.8) 262 (73.0) 97 (27.0) 234 (65.2) 125 (34.8) 246 (68.5) 113 (31.5)
X2 (p-value) 1.674 (p = 0.433) 2.878 (p = 0.237) 10.452 (p = 0.005) 0.201 (p = 0.905) 7.247 (p = 0.027)
Cooked vegetable (portion)
No intake 66 (41.3) 94 (58.8) 97 (60.6) 63 (39.4) 128 (80.0) 32 (20.0) 111 (69.4) 49 (30.6) 126 (78.8) 34 (21.3)
1–4/week 128 (36.4) 224 (63.4) 187 (53.1) 165 (46.9) 291 (82.7) 61 (17.3) 212 (60.2) 140 (39.8) 245 (69.6) 107 (30.4)
5 or more/week 93 (35.8) 173 (65.0) 153 (57.5) 113 (42.5) 188 (70.7) 78 (29.3) 178 (66.9) 88 (33.1) 189 (71.1) 77 (28.9)
X2 (p-value) 1.773 (p = 0.412) 2.812 (p = 0.245) 13.17 (p = 0.001) 5.136 (p = 0.077) 4.736 (p = 0.077)
Whole grains (portion)
No intake 40 (36.4) 70 (63.6) 64 (58.2) 46 (41.8) 81 (73.6) 29 (26.4) 69 (62.7) 41 (37.3) 79 (71.8) 31 (28.2)
1–4/week 54 (37.5) 90 (62.5) 77 (53.5) 67 (46.5) 118 (81.9) 26 (18.1) 8(61.1) 56 (38.9) 105 (72.9) 39 (27.1)
5 or more/week 193 (36.8) 331 (63.2) 296 (56.5) 228 (43.5) 408 (77.9) 116 (22.1) 344 (65.6) 180 (34.4) 376 (71.8) 148 (28.2)
X2 (p-value) 0.037 (p = 0.982) 0.628 (p = 0.73) 2.533 (p = 0.282) 1.17 (p = 0.557) 0.77 (p = 0.962)
Red meat (portion)
No intake 19 (33.3) 38 (66.7) 33 (57.9) 24 (42.1) 41 (71.9) 16 (28.1) 35 (61.4) 22 (38.6) 43 (75.4) 14 (24.6)
1–4/week 167 (37.5) 287 (62.5) 260 (58.4) 185 (41.6) 347 (78.0) 98 (22.0) 290 (65.2) 155 (34.8) 317 (71.2) 128 (28.8)
5 or more/week 101 (36.6) 175 (63.4) 144 (52.2) 132 (47.8) 219 (79.3) 57 (20.7) 176 (63.8) 100 (36.2) 200 (72.5) 76 (27.5)
X2 (p-value) 0.398 (p = 0.82) 2.78 (p = 0.249) 1.517 (p = 0.468) 0.386 (p = 0.825) 0.492 (p = 0.782)
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Table 2. Cont.
Variable
General Dyslipidemia LDL-C HDL-C TC TG
No
(n = 287)
Yes
(n = 491)
Normal
(n = 437)
High
(n = 341)
Normal
(n = 607)
Low
(n = 171)
Normal
(n = 501)
High
(n = 277)
Normal
(n = 560)
High
(n = 218)
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Fresh juice (portion)
No intake 72 (40.2) 107 (59.8) 112 (62.6) 67 (37.4) 133 (74.3) 46 (25.7) 124 (69.3) 55 (30.7) 128 (71.5) 51 (28.5)
1–4/week 141 (34.8) 264 (65.2) 213 (52.6) 192 (47.4) 319 (78.8) 86 (21.2) 249 (61.5) 156 (38.5) 294 (72.6) 111 (27.4)
5 or more/week 74 (38.1) 120 (61.9) 112 (57.7) 82 (42.3) 155 (79.9) 39 (20.1) 128 (66.0) 66 (34.0) 138 (71.1) 56 (28.9)
X2 (p-value) 1.735 (p = 0.42) 5.275 (p = 0.072) 1.973 (p = 0.373) 3.57 (p = 0.168) 0.164 (p = 0.921)
Non fresh juice (portion)
No intake 87 (34.9) 162 (65.1) 141 (56.6) 108 (43.4) 186 (74.7) 63 (25.3) 155 (62.2) 94 (37.8) 179 (71.9 70 (28.1)
1–4/week 97 (38.8) 153 (61.2) 136 (54.4) 114 (45.6) 200 (80.0) 50 (20.0) 158 (63.2) 92 (36.8) 183 (73.2) 67 (26.8)
5 or more/week 103 (36.9) 176 (63.1) 160 (57.3) 119 (42.7) 221 (79.2) 58 (20.8) 188 (67.4) 91 (32.6) 198 (71.0) 81 (29.0)
X2 (p-value) 0.779 (p = 0.671) 0.496 (p = 0.78) 2.404 (p = 0.301) 1.743 (p = 0.418) 0.327 (p = 0.849)
Carbonated drinks
(portion)
No intake 92 (38.2) 149 (61.8) 145 (60.2) 96 (39.8) 184 (76.3) 57 (23.7) 152 (63.1) 89 (36.9) 173 (71.8) 68 (28.2)
1–4/week 88 (37.9) 144 (62.1) 126 (54.3) 106 (45.7) 187 (80.6) 45 (19.4) 155 (66.8) 77 (33.2) 171 (73.7) 61 (26.3)
5 or more/week 107 (35.1) 198 (64.9) 166 (54.4) 139 (45.6) 236 (77.4) 69 (22.6) 194 (63.6) 111 (36.4) 216 (70.8) 89 (29.2)
X2 (p-value) 0.707 (p = 0.702) 2.266 (p = 0.322) 1.369 (p = 0.504) 0.857 (p = 0.615) 0.551 (p = 0.759)
Red tea (portion)
No intake 61 (37.2) 103 (62.8) 98 (59.8) 66 (40.2) 130 (79.3) 34 (20.7) 112 (68.3) 52 (31.7) 124 (75.6) 40 (24.4)
1–4/week 82 (41.6) 115 (58.4) 110 (55.8) 87 (44.2) 168 (85.3) 29 (14.7) 131 (66.5) 66 (33.5) 149 (75.6) 48 (24.4)
5 or more/week 144 (34.5) 273 (65.5) 229 (54.9) 188 (45.1) 309 (74.1) 108 (25.9) 258 (61.9) 159 (38.1) 287 (68.8) 130 (31.2)
X2 (p-value) 2.899 (p = 0.235) 1.132 (p = 0568) 9.938 (p = 0.007) 2.626 (p = 0.269) 4.434 (p = 0.109)
Green tea (portion)
No intake 174 (38.2) 281 (61.8) 263 (57.8) 192 (42.2) 354 (77.8) 101 (22.2) 304 (66.8) 151 (33.2) 329 (72.3) 126 (27.7)
1–4/week 62 (37.6) 103 (62.4) 87 (52.7) 78 (47.3) 135 (81.8) 30 (18.2) 98 (59.4) 67 (40.6) 123 (74.5) 42 (25.5)
5 or more/week 51 (32.3) 107 (67.7) 87 (55.1) 71 (44.9) 118 (74.7) 40 (25.3) 99 (62.7) 59 (37.3) 108 (68.4) 50 (31.6)
X2 (p-value) 1.834 (p = 0.4) 1.365 (p = 0.505) 2.426 (p = 0.297) 3.168 (p = 0.205) 1.592 (p = 0.451)
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Table 2. Cont.
Variable
General Dyslipidemia LDL-C HDL-C TC TG
No
(n = 287)
Yes
(n = 491)
Normal
(n = 437)
High
(n = 341)
Normal
(n = 607)
Low
(n = 171)
Normal
(n = 501)
High
(n = 277)
Normal
(n = 560)
High
(n = 218)
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Arabic coffee (portion)
No intake 124 (36.3) 218 (63.7) 197 (57.6) 145 (42.4) 261 (76.3) 81 (23.7) 218 (63.7) 124 (36.3) 236 (69.0) 106 (31.0)
1–4/week 84 (40.0) 126 (60.0) 112 (53.3) 98 (46.7) 176 (83.8) 34 (16.2) 139 (66.2) 71 (33.8) 163 (77.6) 47 (22.4)
5 or more/week 79 (35.0) 147 (65.0) 128 (56.6) 98 (43.4) 170 (75.2) 56 (24.8) 144 (63.7) 82 (36.3) 161 (71.2) 65 (28.8)
X2 (p-value) 1.294 (p = 0.524) 0.991 (p = 0.609) 5.716 (p = 0.057) 0.404 (p = 0.817) 4.872 (p = 0.087)
Turkish coffee (portion)
No intake 212 (38.0) 346 (62.0) 317 (56.8) 241 (43.2) 434 (77.8) 124 (22.2) 361 (64.7) 197 (35.3) 401 (71.9) 157 (28.1)
1–4/week 54 (44.6) 67 (55.4) 72 (59.5) 49 (40.5) 103 (85.1) 18 (14.9) 87 (71.9) 34 (28.1) 94 (77.7) 27 (22.3)
5 or more/week 21 (21.2) 78 (78.8) 48 (48.5) 51 (51.5) 70 (70.7) 29 (29.3) 53 (53.5) 46 (46.5) 65 (65.7) 34 (34.3)
X2 (p-value) 13.856(p ≤0.001) 3.014 (p = 0.222) 6.667 (p = 0.036) 8.087 (p = 0.018) 3.92 (p = 0.141)
American coffee (portion)
No intake 215 (34.8) 402 (65.2) 341 (55.3) 276 (44.7) 472 (76.5) 145 (23.5) 393 (63.7) 224 (36.3) 435 (70.5) 182 (29.5)
1–4/week 40 (50.0) 40 (50.0) 53 (66.3) 27 (33.8) 69 (86.3) 11 (13.8) 63 (78.8) 17 (21.3) 64 (80.0) 16 (20.0)
5 or more/week 32 (39.5) 49 (60.5) 43 (53.1) 38 (46.9) 66 (81.5) 15 (18.5) 45 (55.6) 36 (44.4) 61 (75.3) 20 (24.7)
X2 (p-value) 7.251(p = 0.027) 3.819 (p = 0.148) 4.558 (p = 0.102) 10.082 (p = 0.006) 3.664 (p = 0.16)
Cappuccino (portion)
No intake 195 (36.9) 333 (63.1) 298 (56.4) 230 (43.6) 404 (76.5) 124 (23.5) 342 (64.8) 186 (35.2) 380 (72.0) 148 (28.0)
1–4/week 64 (41.6) 90 (58.4) 88 (57.1) 66 (42.9) 130 (84.4) 24 (15.6) 104 (67.5) 50 (32.5) 114 (74.0) 40 (26.0)
5 or more/week 28 (29.2) 68 (70.8) 51 (53.1) 45 (46.9) 73 (76.0) 23 (24.0) 55 (57.3) 41 (42.7) 66 (68.8) 30 (31.3)
X2 (p-value) 3.902 (p = 0.142) 0.436 (p = 0.804) 4.59 (p = 0.101) 2.807 (p = 0.246) 0.816 (p = 0.665)
Energy drinks (portion)
No intake 219 (35.7) 395 (64.3) 338 (55.0) 276 (45.0) 468 (76.2) 146 (23.8) 389 (63.4) 225 (36.6) 432 (70.4) 182 (29.6)
1–4/week 45 (39.8) 68 (60.2) 65 (57.5) 48 (42.5) 96 (85.0) 17 (15.0) 74 (65.5) 39 (34.5) 86 (76.1) 27 (23.9)
5 or more/week 23 (45.1) 28 (54.9) 34 (66.7) 17 (33.3) 43 (84.3) 8 (15.7) 38 (74.5) 13 (25.5) 42 (82.4) 9 (17.6)
X2 (p-value) 2.287 (p = 0.319) 2.68 (p = 0.262) 5.506 (p = 0.064) 2.624 (p = 0.269) 4.475 (p = 0.107)
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Table 2. Cont.
Variable
General Dyslipidemia LDL-C HDL-C TC TG
No
(n = 287)
Yes
(n = 491)
Normal
(n = 437)
High
(n = 341)
Normal
(n = 607)
Low
(n = 171)
Normal
(n = 501)
High
(n = 277)
Normal
(n = 560)
High
(n = 218)
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Hibiscus drinks (portion)
No intake 271 (38.4) 435 (61.6) 406 (57.5) 300 (42.5) 557 (78.9) 149 (21.1) 460 (65.2) 246 (34.8) 516 (73.1) 190 (26.9)
1–4/week 12 (20.7) 46 (79.3) 24 (41.4) 34 (58.6) 40 (69.0) 18 (31.0) 34 (58.6) 24 (41.4) 36 (62.1) 22 (37.9)
5 or more/week 4 (28.6) 10 (71.4) 7 (50.0) 7 (50.0) 10 (71.4) 4 (28.6) 7 (50.0) 7 (50.0) 8 (57.1) 6 (42.9)
X2 (p-value) 7.633(p = 0.022) 5.883 (p = 0.053) 3.443 (p = 0.179) 2.287 (p = 0.319) 4.782 (p = 0.092)
Cinnamon drink (portion)
No intake 268 (38.6) 426 (61.4) 398 (57.3) 296 (42.7) 549 (79.1) 145 (20.9) 457 (65.9) 237 (34.1) 511 (73.6) 183 (26.4)
1–4/week 11 (21.2) 41 (78.8) 22 (42.3) 30 (57.7) 36 (69.2) 16 (30.8) 24 (46.2) 28 (53.8) 29 (55.8) 23 (44.2)
5 or more/week 8 (25.0) 24 (75.0) 17 (53.1) 15 (46.9) 22 (68.8) 10 (31.3) 20 (62.5) 12 (37.5) 20 (62.5) 12 (37.5)
X2 (p-value) 8.363 (p = 0.015) 4.571 (p = 0.102) 4.424 (p = 0.109) 8.238 (p = 0.016) 9.139 (p = 0.01)
Data are shown as frequency and percentages. χ2 is the Chi-square test value followed by its p-value. Significant differences between groups are shown in bold font LDL-C, low-density
lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides.
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Table 3. Unadjusted and adjusted Odds Ratios (OR) with its 95% Confidence Interval (CI) for dietary
and lifestyle predictors of dyslipidemia in men.
Covariate
Unadjusted Adjusted for Age, BMI and WC
OR (95% CI) P OR (95% CI) P
Turkish coffee intake
p for trend p < 0.001 p = 0.001
No intake (reference)
1–4 /week 0.955 (0.604, 1.512) p = 0.846 0.929 (0.573, 1.507) p = 0.766
5 or more /week 2.783 (1.566, 4.944) p < 0.001 2.737 (1.532, 4.889) p = 0.001
American coffee intake
p for trend p = 0.005 p = 0.025
No intake (reference)
1–4 /week 0.469 (0.273, 0.805) p = 0.006 0.577 (0.326, 1.021) p = 0.059
5 or more /week 0.544 (0.318, 0.933) p = 0.027 0.525 (0.298, 0.923) p = 0.025
Carbonated drinks intake
p for trend p > 0.15 p = 0.093
No intake (reference)
1–4 /week 1.226 (0.815, 1.842) p = 0.326
5 or more /week 1.533 (1.041, 2.257) p = 0.03
Sleep duration
p for trend p = 0.011 p = 0.012
6–8 h (reference)
<6 h 1.566 (1.155, 2.123) p = 0.004 1.573 (1.137, 2.175) p = 0.006
>8 h 1.545 (0.795, 3.003) p = 0.2 1.844 (0.88, 3.864) p = 0.105
Smoking
p for trend p > 0.15 p = 0.073
Non-smokers (reference)
Smokers 1.41 (1.001, 1.986) p = 0.043
Previous smokers 0.755 (0.381, 1.497) p = 0.422
Variables having a p > 0.15 in the initial logistic regression analysis between the dependent and independent
variables were not included in the stepwise regression model. Significant differences between groups are shown in
bold font.
3.2.2. Association between Food Intake and Dyslipidemia in Women
Comparing dietary habits in women between the two groups of normolipidemia and dyslipidemia,
a high intake of the cinnamon drink was significantly associated with dyslipidemia in general (p = 0.027)
and high LDL-C (p = 0.036) and TC in specific (p = 0.002) (Table 4). Dyslipidemia was present in 77%
of women drinking five or more portions a week cinnamon drink compared to 58% in women who do
not. The weekly intake of five or more portions of the cinnamon drink was associated with 2.6 times
increased odds for having dyslipidemia in women compared with those with no intake. However,
after adjusting for age, BMI, and WC, these odds became insignificant (Table 5). The adjustment for age
and BMI regression analysis for each type of dyslipidemia separately showed that the weekly intake
of five or more portions of the cinnamon drink was associated with a 2.57 times increased odds for
having high TC in women compared with those with no intake (OR = 2.57; 95% CI: 1.22, 5.42; p = 0.02),
but this was not significant after adjustment for age, BMI, and WC.
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Table 4. Comparison of dietary habits between normolipidemic and dyslipidemic women groups presented as the number of women and (% of the group) for overall
dyslipidemia, and abnormalities in different lipid fractions.
Variable
General Dyslipidemia LDL-C HDL-C TC TG
No
(n = 240)
Yes
(n = 367)
Normal
(n = 381)
High
(n = 226)
Normal
(n = 440)
Low
(n = 167)
Normal
(n = 404)
High
(n = 203)
Normal
(n = 524)
High
(n = 82)
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Fruit (portion)
No intake 33 (47.1) 37 (52.9) 47 (67.1) 23 (32.9) 56 (80.0) 14 (20.0) 53 (75.7) 17 (24.3) 61 (87.1) 9 (12.9)
1–4/week 123 (38.2) 199 (61.8) 209 (64.9) 113 (35.1) 219 (68.0) 103 (32.0) 221 (68.6) 101 (31.4) 284 (88.2) 38 (11.8)
5 or more/week 84 (39.1) 131 (60.9) 125 (58.1) 90 (41.9) 165 (76.7) 50 (23.3) 130 (60.5) 85 (39.5) 179 (83.3) 36 (16.7)
X2 (p-value) 1.955 (p = 0.372) 3.174 (p = 0.204) 7.168 (p = 0.028) 6.846 (p = 0.033) 2.713 (p = 0.258)
Fresh vegetable (portion)
No intake 33 (62.3) 20 (37.7) 42 (79.2) 11 (20.8) 44 (83.0) 9 (17.0) 45 (84.9) 8 (15.1) 50 (94.3) 3 (5.7)
1–4/week 79 (35.3) 145 (64.7) 137 (61.2) 87 (38.8) 152 (67.9) 72 (32.1) 150 (67.0) 74 (33.0) 194 (86.6) 30 (13.4)
5 or more/week 128 (28.8) 202 (61.2) 202 (61.2) 128 (38.8) 244 (73.9) 86 (26.1) 209 (63.3) 121 (36.7) 280 (84.8) 50 (15.2)
X2 (p-value) 13.237 (p <0.001) 6.747 (p = 0.034) 5.704 (p = 0.058) 9.574 (p = 0.008) 3.509 (p = 0.173)
Cooked vegetable (portion)
No intake 32 (48.5) 34 (51.5) 42 (63.6) 24 (36.4) 53 (80.3) 13 (19.7) 51 (77.3) 15 (22.7) 58 (87.9) 8 (12.1)
1–4/week 100 (36.1) 177 (63.9) 172 (62.1) 105 (37.9) 195 (70.4) 82 (29.6) 176 (63.5) 101 (36.5) 237 (85.6) 40 (14.4)
5 or more/week 108 (40.9) 156 (59.1) 167 (63.3) 97 (36.7) 192 (72.7) 72 (27.3) 177 (67.0) 87 (33.0) 229 (86.7) 35 (13.3)
X2 (p-value) 3.786 (p = 0.151) 0.102 (p = 0.95) 2.636 (p = 0.268) 4.567 (p = 0.102) 0.311 (p = 0.856)
Whole grains (portion)
No intake 40 (44.0) 51 (56.0) 61 (67.0) 30 (33.0) 64 (70.3) 27 (29.7) 66 (72.5) 25 (27.5) 81 (89.0) 10 (11.0)
1–4/week 34 (37.4) 57 (62.6) 54 (59.3) 37 (40.7) 65 (71.4) 26 (28.6) 57 (62.6) 34 (37.4) 76 (83.5) 15 (16.5)
5 or more/week 166 (39.1) 259 (60.9) 266 (62.6) 159 (37.4) 311 (73.2) 114 (26.8) 281 (66.1) 144 (33.9) 367 (86.4) 58 (13.6)
X2 (p-value) 0.964 (p = 0.618) 1.172 (p = 0.557) 0.365 (p = 0.833) 2.122 (p = 0.346) 1.165 (p = 0.559)
Red meat (portion)
No intake 65 (46.8) 74 (53.2) 92 (66.2) 47 (33.8) 105 (75.5) 34 (24.5) 95 (68.3) 44 (31.9) 122 (87.8) 17 (12.2)
1–4/week 113 (33.7) 222 (66.3) 204 (60.9) 131 (39.1) 231 (69.0) 104 (31.0) 217 (64.8) 118 (35.2) 287 (85.7) 48 (14.3)
5 or more/week 62 (46.6) 71 (53.4) 85 (63.9) 48 (36.1) 104 (78.2) 29 (21.8) 92 (69.2) 41 (30.8) 115 (86.5) 18 (13.5)
X2 (p-value) 10.547 (p = 0.005) 1.272 (p = 0.529) 4.918 (p = 0.086) 1.086 (p = 0.581) 0.369 (p = 0.831)
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Table 4. Cont.
Variable
General Dyslipidemia LDL-C HDL-C TC TG
No
(n = 240)
Yes
(n = 367)
Normal
(n = 381)
High
(n = 226)
Normal
(n = 440)
Low
(n = 167)
Normal
(n = 404)
High
(n = 203)
Normal
(n = 524)
High
(n = 82)
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Fresh juice (portion)
No intake 78 (42.2) 107 (57.8) 118 (63.8) 67 (36.2) 134 (72.4) 51 (27.6) 127 (68.6) 58 (31.4) 167 (90.3) 18 (9.7)
1–4/week 103 (36.9) 176 (63.1) 174 (62.4) 105 (37.6) 198 (71.0) 81 (29.0) 181 (64.9) 98 (35.1) 236 (84.6) 43 (15.4)
5 or more/week 59 (41.3) 84 (58.7) 89 (62.2) 54 (37.8) 108 (75.5) 35 (24.5) 96 (67.1) 47 (32.9) 121 (84.6) 22 (15.4)
X2 (p-value) 1.511 (p = 0.47) 0.118 (p = 0.943) 0.985 (p = 0.611) 0.74 (p = 0.691) 3.507 (p = 0.173)
Non fresh juice (portion)
No intake 93 (36.0) 165 (64.0) 158 (61.2) 100 (38.8) 183 (70.9) 75 (29.1) 160 (62.0) 98 (38.0) 220 (85.3) 38 (14.7)
1–4/week 74 (38.9) 116 (61.1) 123 (64.7) 67 (35.3) 136 (71.6) 54 (28.4) 134 (70.5) 56 (29.5) 164 (86.3) 26 (13.7)
5 or more/week 73 (45.9) 86 (54.1) 100 (62.9) 59 (37.1) 121 (76.1) 38 (23.9) 110 (69.2) 49 (30.8) 140 (88.1) 19 (11.9)
X2 (p-value) 4.046 (p = 0.132) 0.574 (p = 0.751) 1.433 (p = 0.488) 4.228 (p = 0.121) 0.644 (p = 0.725)
Carbonated drinks
(portion)
No intake 113 (38.2) 183 (61.8) 182 (61.5) 114 (38.5) 207 (69.9) 89 (30.1) 193 (65.2) 103 (34.8) 248 (83.8) 48 (16.2)
1–4/week 68 (39.1) 106 (60.9) 108 (62.1) 66 (37.9) 130 (74.7) 44 (25.3) 115 (66.1) 59 (33.9) 156 (89.7) 18 (10.3)
5 or more/week 59 (43.1) 78 (56.9) 91 (66.4) 46 (33.6) 103 (75.2) 34 (24.8) 96 (70.1) 41 (29.9) 120 (87.6) 17 (12.4)
X2 (p-value) 0.958 (p = 0.619) 1.028 (p = 0.598) 1.9 (p = 0.387) 1.022 (p = 0.6) 3.44 (p = 0.179)
Red tea (portion)
No intake 79 (43.4) 103 (56.6) 125 (68.7) 57 (31.3) 129 (70.9) 53 (29.1) 136 (74.7) 46 (25.3) 161 (88.5) 21 (11.5)
1–4/week 42 (32.1) 89 (67.9) 75 (57.3) 56 (42.7) 91 (69.5) 40 (30.5) 77 (58.8) 54 (41.2) 110 (84.0) 21 (16.0)
5 or more/week 119 (40.5) 175 (59.5) 181 (61.6) 113 (38.4) 220 (74.8) 74 (25.2) 191 (65.0) 103 (35.0) 253 (86.1) 41 (13.9)
X2 (p-value) 4.311 (p = 0.116) 4.611 (p = 0.1) 1.645 (p = 0.439) 9.351 (p = 0.009) 1.338 (p = 0.512)
Green tea (portion)
No intake 134 (41.9) 186 (58.1) 215 (67.2) 105 (32.8) 227 (70.9) 93 (29.1) 226 (70.6) 94 (29.4) 281 (87.8) 39 (12.2)
1–4/week 50 (38.5) 80 (61.5) 75 (57.7) 55 (42.3) 94 (72.3) 36 (27.7) 85 (65.4) 45 (34.6) 108 (83.1) 22 (16.9)
5 or more/week 56 (35.7) 101 (64.3) 91 (58.0) 66 (42.0) 119 (75.8) 38 (24.2) 93 (59.2) 64 (40.8) 135 (86.0) 22 (14.0)
X2 (p-value) 1.777 (p = 0.411) 5.659 (p = 0.059) 1.249 (p = 0.535) 6.24 (p = 0.044) 1.777 (p = 0.411)
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Table 4. Cont.
Variable
General Dyslipidemia LDL-C HDL-C TC TG
No
(n = 240)
Yes
(n = 367)
Normal
(n = 381)
High
(n = 226)
Normal
(n = 440)
Low
(n = 167)
Normal
(n = 404)
High
(n = 203)
Normal
(n = 524)
High
(n = 82)
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Arabic coffee (portion)
No intake 93 (40.4) 137 (59.6) 148 (64.3) 82 (35.7) 161 (70.0) 69 (30.0) 159 (69.1) 71 (30.9) 199 (86.5) 31 (13.5)
1–4/week 57 (37.3) 96 (62.7) 98 (64.1) 55 (35.9) 104 (68.0) 49 (32.0) 104 (68.0) 49 (32.0) 130 (85.0) 23 (15.0)
5 or more/week 90 (40.2) 134 (59.8) 135 (60.3) 89 (39.7) 175 (78.1) 49 (21.9) 141 (62.9) 83 (37.1) 195 (87.1) 29 (12.9)
X2 (p-value) 0.449 (p = 0.799) 0.953 (p = 0.621) 5.846 (p = 0.054) 2.134 (p = 0.344) 0.347 (p = 0.841)
Turkish coffee (portion)
No intake 170 (39.1) 265 (60.9) 280 (64.4) 155 (35.6) 310 (71.3) 125 (28.7) 284 (65.3) 151 (34.7) 378 (86.9) 57 (13.1)
1–4/week 31 (33.7) 61 (66.3) 52 (56.5) 40 (43.5) 65 (70.7) 27 (29.3) 64 (69.6) 28 (30.4) 77 (83.7) 15 (16.3)
5 or more/week 39 (48.8) 41 (51.2) 49 (61.3) 31 (38.8) 65 (81.3) 15 (18.8) 56 (70.0) 24 (30.0) 69 (86.3) 11 (13.8)
X2 (p-value) 4.192 (p = 0.123) 2.091 (p = 0.351) 3.562 (p = 0.168) 1.115 (p = 0.573) 0.66 (p = 0.719)
American coffee (portion)
No intake 212 (40.2) 315 (59.8) 332 (63.0) 195 (37.0) 382 (72.5) 145 (27.5) 353 (67.0) 174 (33.0) 460 (87.3) 67 (12.7)
1–4/week 12 (27.9) 31 (72.1) 27 (62.8) 16 (37.2) 27 (62.8) 16 (37.2) 30 (69.8) 13 (30.2) 34 (79.1) 9 (20.9)
5 or more/week 16 (43.2) 21 (56.8) 22 (59.5) 15 (40.5) 31 (83.8) 6 (16.2) 21 (56.8) 16 (43.2) 30 (81.1) 7 (18.9)
X2 (p-value) 2.751 (p = 0.253) 0.185 (p = 0.912) 4.395 (p = 0.111) 1.839 (p = 0.300) 3.192 (p = 0.203)
Cappuccino (portion)
No intake 140 (38.6) 223 (61.4) 216 (59.5) 147 (40.5) 255 (70.2) 108 (29.8) 238 (65.6) 125 (34.4) 306 (84.3) 57 (15.7)
1–4/week 60 (43.2) 79 (56.8) 99 (71.2) 40 (28.8) 104 (74.8) 35 (25.2) 98 (70.5) 41 (29.5) 123 (88.5) 16 (11.5)
5 or more/week 40(38.1) 65 (61.9) 66 (62.9) 39 (37.1) 81 (77.1) 24 (22.9) 68 (64.8) 37 (35.2) 95 (90.5) 10 (9.5)
X2 (p-value) 1 (p = 0.607) 5.907 (p = 0.052) 2.433 (p = 0.296) 1.285 (p = 0.526) 3.349 (p = 0.187)
Energy drinks (portion)
No intake 212 (39.3) 328 (60.7) 334 (61.9) 206 (38.1) 388 (71.9) 152 (28.1) 356 (65.9) 184 (34.1) 464 (85.9) 76 (24.1)
1–4/week 15 (33.3) 30 (66.7) 31 (68.9) 14 (31.1) 32 (71.1) 13 (28.9) 30 (66.7) 15 (33.3) 40 (88.9) 5 (11.1)
5 or more/week 13 (59.1) 9 (40.9) 16 (72.7) 6 (27.3) 20 (90.9) 2 (9.1) 18 (81.8) 4 (18.2) 20 (90.0) 2 (9.1)
X2 (p-value) 2.261 (p = 0.119) 1.849 (p = 0.397) 3.896 (p = 0.143) 2.399 (p = 0.301) 0.715 (p = 0.699)
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Table 4. Cont.
Variable
General Dyslipidemia LDL-C HDL-C TC TG
No
(n = 240)
Yes
(n = 367)
Normal
(n = 381)
High
(n = 226)
Normal
(n = 440)
Low
(n = 167)
Normal
(n = 404)
High
(n = 203)
Normal
(n = 524)
High
(n = 82)
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Hibiscus drinks (portion)
No intake 220 (39.9) 331 (60.1) 352 (63.9) 199 (36.1) 396 (71.9) 155 (28.1) 374 (67.9) 177 (32.1) 474 (86.0) 77 (14.0)
1–4/week 15 (35.7) 27 (64.3) 21 (50.0) 21 (50.0) 32 (76.2) 10 (23.8) 24 (57.1) 18 (42.9) 38 (90.5) 4 (9.5)
5 or more/week 5 (35.7) 9 (64.3) 8 (57.1) 6 (42.9) 12 (85.7) 2 (14.3) 6 (42.9) 8 (57.1) 12 (85.7) 2 (14.3)
X2 (p-value) 0.377 (p = 0.828) 3.413 (p = 0.182) 1.622 (p = 0.444) 5.636 (p = 0.06) 0.659 (p = 0.719)
Cinnamon drink (portion)
No intake 200 (42.2) 274 (57.8) 310 (65.4) 164 (34.6) 348 (73.4) 126 (26.6) 328 (69.2) 146 (30.8) 412 (86.9) 62 (13.1)
1–4/week 32 (32.30) 67 (67.7) 54 (54.5) 45 (45.5) 70 (70.7) 29 (29.3) 62 (62.6) 37 (37.4) 85 (85.9) 14 (14.1)
5 or more/week 8 (23.5) 26 (76.5) 17 (50.0) 17 (50.0) 22 (64.7) 12 (35.3) 14 (41.2) 20 (58.8) 27 (79.4) 7 (20.6)
X2 (p-value) 7.199 (p = 0.027) 6.642 (p = 0.036) 1.395 (p = 0.498) 12.013 (p = 0.002) 1.537 (p = 0.464)
Data are shown as frequency and percentages. χ2 is the Chi-square test value followed by its p-value. Significant differences between groups are shown in bold font. LDL-C, low-density
lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides.
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Table 5. Unadjusted and adjusted Odds Ratio (OR) with its 95% Confidence Interval (CI) for the
predictors of dyslipidemia in women.
Covariate
Unadjusted Adjusted for Age, BMI and WC
OR (95% CI) P OR (95% CI) P
Fresh vegetables intake
p for trend p = 0.007 p = 0.024
No intake (reference)
1–4/week 2.683 (1.416, 5.085) p = 0.002 2.499 (1.285, 4.859) p = 0.007
5 or more/week 2.489 (1.34, 4.624) p = 0.004 2.072 (1.089, 3.941) p = 0.026
Cinnamon drink intake
p for trend p = 0.027 p > 0.15
No intake (reference)
1–4/week 1.395 (0.873, 2.228) p = 0.163
5 or more/week 2.613 (1.142, 5.978) p = 0.023
Variables having a p > 0.15 in the initial logistic regression analysis between the dependent and independent
variables were not included in the stepwise regression model. Significant differences between groups are shown in
bold font.
Moderate and high intakes of fresh vegetables were also found to be significantly associated with
dyslipidemia (p < 0.001; Table 4) and mainly high LDL-C and TC (p = 0.034 and p = 0.008 respectively,
Table 4). Dyslipidemia was diagnosed in 61% and 65% of women who ate either five or more portions
of fresh vegetables/week or 1–4 times per week respectively compared to 38% of women who did
not. This was associated with 2.50 and 2.07 times increased odds of having dyslipidemia, respectively,
compared with those with no intake after adjusting for age, BMI, and WC (OR = 0.50 (95% CI: 1.29,
4.86) p = 0.007 and OR = 2.07 (95% CI: 1.09, 3.94) p = 0.026 respectively; Table 5).
Following the finding of this interesting results, further analysis was performed to identify the
characteristics of females with high intake of fresh vegetables. Women who reported to have an intake
of 1–4 and 5 or more portions per week were significantly older than those who reported no intake
(p <0.01 at least). They also had a significantly higher mean weight and neck circumference (p <0.05 at
least). In addition, a higher proportion of these women were previously diagnosed with dyslipidemia
and taking medication, however, this was not statistically significant (Supplementary Table S3).
There was no effect of other food types on dyslipidemia in women when analyzed using regression
analysis after adjusting for age, BMI, and WC.
3.3. Association between Lifestyle Characteristics and Dyslipidemia in Men and Women
After analyzing sex groups separately, only short and long sleep durations were associated with
general dyslipidemia in men only (Supplementary Table S2a, p = 0.012). Dyslipidemia was detected in
68.5% and 68.2% of men who reported sleeping either <6 h/day, or >8 h/day respectively compared
with 58.1% of people who slept 6–8 h per day. This association was particularly evident for increased
TC (p < 0.029). There was no association between sleep duration and dyslipidemia in women.
There was no association between physical activity or daily sitting duration and dyslipidemia in
general (Supplementary Table S2a,b). However, low physical activity was associated with high TC and
TG in men (p = 0.024 and p = 0.048 respectively; Supplementary Table S2a). High TC and TG were
detected in 39.1% and 30.9% of men reporting low physical activity compared with 31.3% and 24.5%,
respectively, in men who were more physically active. In women, low physical activity was associated
with low HDL-C only (p = 0.024; Supplementary Table S2b). Low HDL-C was detected in 41% of
women reporting low physical activity compared with 32% of women who were more physically
active. On the other hand, very short sitting duration (<4 h per day) was associated with decreased
HDL-C in women as it was found in 36.3% of women reporting sitting for <4 h per day compared with
20–26% of those sitting for more than 4 h (p = 0.031, Supplementary Table S2b).
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Smoking was not associated with dyslipidemia in general (Supplementary Table S2a,b). However,
it was associated with high TG in men (p = 0.011; Supplementary Table S2a). High TG was detected
in 34.2% of men who smoke compared with 25.7% of non-smoking men. In women, smoking was
associated with low HDL-C (p = 0.035; Supplementary Table S2b). Low HDL-C was detected in 50% of
women who smoked compared with 36.1% of who were non-smokers.
After adjusting for age, BMI, and WC, only sleep duration and smoking were predictors for
dyslipidemia in men (Table 3). Having <6 h of sleep per day was associated with increased odds of
having general dyslipidemia compared with those sleeping 6–8 h (OR = 1.57 (CI: 1.14, 2.18) p = 0.006;
Table 3). In addition, smoking was associated with increased odds of having general dyslipidemia
compared with those who did not smoke (OR = 1.42 (CI: 1.00, 1.98) p = 0.043; Table 3).
Lifestyle characteristics were not predictors for dyslipidemia in women after adjusting for age,
BMI, and WC.
4. Discussion
In this study, we investigated the association between dyslipidemia, dietary, and other lifestyle
practices among Saudi adults not previously diagnosed with diabetes. Dyslipidemia was found to
be associated with increased age, BMI, and WC in men and women. However, notable differences
between sexes in the association of dyslipidemia with dietary and other lifestyle practices were noted.
In men, an increased risk of dyslipidemia was found to be associated with high consumption of Turkish
coffee, and carbonated drinks, short (<6 h) and long (>8 h) sleep duration, and smoking, while high
consumption of American coffee was associated with decreased risk after adjusting for age, BMI and
WC. However, only increased consumption of fresh vegetables was associated with an increased risk
of dyslipidemia in women after adjusting for confounding factors.
The prevalence of dyslipidemia among Saudi adults in our study was 62% which is higher than
previously reported [10,11]. The difference could be due to the variations in dietary, and lifestyle
practices between regions of the Kingdom as well ethnic origin of studied populations since ethnicity
among Saudi nationals can vary to some extent and influence genetic and lifestyle factors. Our study
was conducted in the city of Jeddah in the Western Region of the Kingdom, while the previous
study [10,11] included people from all the regions in Saudi Arabia. Another reason could be the
variation in defining dyslipidemia and all its types. In this study, the used dyslipidemia definition
was more comprehensive as it included laboratory-measured high TG, high fasting serum cholesterol,
low fasting plasma HDL-C and/or high fasting plasma LDL-C levels, as well as treatment with
hyperlipidemic drugs [27,28].
The most prevalent type of dyslipidemia in this study was high LDL-C which was detected in
40.9% of studied Saudi adults. This was followed by high TC in 34.7%, low HDL-C in 24.4%, and least
of all high TG levels in 21.7% of the study population. A comparably high prevalence of high LDL-C
and hypercholesterolemia in a Saudi population was reported in previous large community-based
national cross-sectional studies [9–11]. However, one of these studies [9] reported a much higher
prevalence for hypertriglyceridemia despite using similar definition. This could be caused by the
difference in the age range of participants as the previous study [9] included people aged 30–70 years,
whereas the current study included adults ≥18 years of age.
As reported in previous studies on Saudi and other populations [9–11,30,31] older age, increased
BMI and WC were associated with a higher prevalence of dyslipidemia in general, and all its types.
The prevalence of high TG in the current study was lower than previously reported [11] being 11.4%
for young adults aged 30 years or under compared to with 32% in the older adults aged more than
30 years. This difference in prevalence is due to the variation in the cut-off point to determine
hypertriglyceridemia as it was ≥ 1.7 mmol/L in our study as well as in that of Al-Amri et al. [32]
whereas ≥ 1.27 mmol/L was adopted in the previous study [11]. The cut-off point in this previous study
allowed a wider range of the population to be diagnosed with hypertriglyceridemia, and therefore a
higher prevalence was reported.
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In our study sex had no effect on the prevalence of dyslipidemia in general but both
hypertriglyceridemia and high LDL-C were more prevalent in men than women. Similar sex-differences
were reported previously [9,11]. This could be due to the higher proportion of smokers, and the higher
prevalence of low sleep duration (<6 h) among men. These lifestyle factors were associated with both
hypertriglyceridemia and elevated LDL-C in this study. On the other hand, low HDL-C was more
prevalent among women, which is different from that previously reported [11]. Similar sex differences
in the prevalence of low HDL-C was previously found in Iranian population [33], which reported a
much higher prevalence in both men and women compared with that found in our study.
Emerging evidence collected from self-reported data indicated that both short and long sleep
duration are associated with adverse health consequences including obesity hypertension, diabetes
mellitus, and CVDs, showing a curvilinear relationship between habitual sleep duration and these
conditions [34–36]. In line with this, in our study in men but not in women, both short (<6 h) and
long (>8 h) sleep durations were associated with dyslipidemia, particularly with elevated LDL-C and
TG levels. In contrast, a recent systemic review, meta-analysis, and meta-regression suggested that
a causal relationship existed between short sleep durations and adverse health outcomes including
increased risk of diabetes, hypertension, and CVD [14]. However, there was insufficient data to draw a
conclusion regarding the association between short sleep duration and dyslipidemia [14,34]. On the
other hand, another systematic review indicated that long sleep may have more adverse health effect
than short sleep [37]. Findings from cross-sectional data for the middle-aged and older Chinese
population partly supported our finding that both short and long sleep durations were associated with
dyslipidemia; since their cohort data suggested that long sleep duration (>9 h) only was associated
with dyslipidemia [35].
In experimental studies, sleep debt has shown to induce alterations in the endocrine functions,
so that sleep debt for 4 h resulted in raising evening cortisol concentrations, suggesting that it
results in the disturbance of the negative-feedback regulation of the hypothalamus-pituitary-adrenal
axis [37,38]. A previous cross-sectional study reported that excess cortisol secretion was linked to
increased TG concentrations in South Asians [39]. The association between sleep duration, cortisol
secretion, and dyslipidemia needs to be further investigated [40]. Even though the cortisol level
was not measured in our study, dysregulated cortisol secretion might be the cause for the observed
association between short sleep duration and dyslipidemia.
High consumption of Turkish coffee in this study was associated with dyslipidemia in men only.
This is consistent with findings from previous clinical studies [41]. In contrast, we found that high
consumption of American coffee was associated with decreased risk of dyslipidemia in men also, which
contradicts findings in a clinical cohort study reporting that abstention from filtered coffee for 3 weeks
resulted in a decrease in TC [42]. In an attempt to explain the different findings, a previous review
suggested that brewing and preparation techniques influence this association as the long contact of
beans with hot water in unfiltered coffee results in the formation of cholesterol elevating compounds,
such as cafestol and kahweol, and that up to 90% of these diterpenes may be carried by floating coffee
bean particles [43]. The same review suggested that the predicted rise in serum cholesterol levels
with consumption of five cups of Turkish coffee per day is 0.25 mmol/L whereas filtered coffee is not
predicted to increase serum cholesterol levels. In addition to diterpene alcohols, other compounds are
found in the complex coffee beverage [43]. Moreover, a previous meta-regression analysis revealed that
coffee consumption, particularly unfiltered coffee, is related to increased LDL-C, TC, and TG in a dose
dose-dependent manner [42]. Coffee also contains antioxidant and anti-inflammatory compounds
such as chlorogenic acid [43]. This might explain the observed U-shaped relationship between coffee
consumption and low HDL-C and high TC in the current study. The observation that Turkish coffee
was related to increased dyslipidemia in men but not women in the current study cannot be explained
by variation in consumption patterns between sexes since these were comparable. Similar to our
findings, a previous Norwegian study reported that unfiltered coffee consumption was associated with
elevated cholesterol levels in men but not women [44].
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In the current study fruit and vegetable intake were associated with dyslipidemia in men in a
U-shaped manner. However, following adjustment for age, BMI, and WC consumption of fruits and
vegetables lost their association with dyslipidemia in men. This suggests that this association could be
caused by the high intake of total food in general and thus confounded by other constituents of diet.
On the other hand, the consumption of fruit and fresh vegetables was associated with an increased
risk of dyslipidemia, particularly elevated TC, in women, thus contradicting the previously reported
beneficial effects of fruits and vegetables on serum lipids [45]. However, following adjustment for age,
BMI, and WC, only the consumption of fresh vegetables retained its association with dyslipidemia.
This could be a chance finding given several statistical comparisons, or due to the residual confounding
since we did not collect data on all possible factors that may be associated with dyslipidemia. Following
this unexpected finding, further statistical analysis was carried out, and the mean neck circumference
(NC) was found to be higher in women reporting medium and high intake of fresh vegetables. In a
systemic review and meta-analysis, positive associations between NC, high TC, and LDL-C, and low
HDL-C concentrations were found, and subjects with higher NC had approximately two-fold higher
risk for hypertriglyceridemia compared to those with lower NC [46]. NC was not adjusted for in
our study, hence its increased mean in women consuming fresh vegetables could contribute to the
noted association. Another reason could be that women who knew about their dyslipidemia or were
trying to lose weight had modified their diet to include more fresh vegetables, i.e., representing reverse
causation. Indeed, the mean weight of women ingesting fresh vegetables was significantly higher than
the mean of those reporting no intake, and a higher percentage were on lipid-lowering therapy, but
the difference to those reporting no intake did not reach statistical significance. Also, the addition of
salad dressings to fresh vegetable salads is a very common dietary practice. Salad dressings often
contain around 40% of fat, and a considerable amount of high fructose corn syrup, which has been
proven to increase lipid synthesis and is associated with dyslipidemia [47]. Furthermore, mayonnaise
is a major ingredient as a salad dressing alone or as part of other popular dressings (e.g., thousand
islands), and studies have found that the use of palm oil, a cheaper oil comparatively, in its preparation
caused an increase in total and LDL-C compared to the use of soybean oil, which is a more expensive
type [48]. Therefore, the consumption of dressing can distort potential beneficial influences of vegetable
consumption on serum lipids.
Studies with more detailed dietary assessment methods such as food diaries that provide
information about consumed additives to vegetables are required to get a clear picture of the influence
of vegetable consumption on serum lipids in Saudis.
It was interesting to note that in men, smoking and high consumption of carbonated drinks
were significantly associated with dyslipidemia only following adjustment for age, BMI, and WC.
Both cigarette smoking and dyslipidemia are well-established major risk factors for cardiovascular
disease. Studies on different populations reported an increased risk of dyslipidemia in smokers [1–3].
A Korean cross-sectional study [49] conducted in adults aged ≥19 years reported that there was an
increased risk of low HDL-C, high TG and high LDL-C in male smokers compared with non-smokers.
On the other hand, female smokers were found to have a significantly increased risk for high TC,
high TG, and high LDL-C compared with non-smokers. These results emphasize the sex difference in
response to the same lifestyle factors as noted in our study. A Tunisian study [50] reported an increased
risk of high triglyceridemia, and low HDL-C in smokers in a dose-response manner. Our study did not
investigate the amount or type of smoking, however it was noted that a higher percentage of smokers
had hypertriglyceridemia. Similar findings were reported in a Chinese study of elderly adults [51] that
concluded that smoking was an independent risk factor for dyslipidemia and that it had a bigger effect
than other studied factors including alcohol intake, BMI, and age.
High consumption of carbonated drinks was a predictor of dyslipidemia in men. A prospective
study reported that daily consumption of carbonated drinks was associated with increased risk
of hypertriglyceridemia and low HDL-C. In a cross-sectional study performed in Oslo, Norway,
the consumption of colas but not other carbonated drinks was associated with low serum HDL-C,
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as well as high TG and LDL-C [52]. The association between high carbonated drink intake and
dyslipidemia could be attributed to the high sucrose content in these drinks as it was reported to be
linked to hypertriglyceridemia previously [53]. The questionnaire that was used in this study did not
provide specific data about the type of carbonated drink. Future work should include more details on
type of drinks, and whether it was sugar-free or not.
A number of lifestyle practices showed an association initially, but this association was lost after
adjustment for confounding factors. These practices include decreased physical activity and sitting
duration. Physical activity and sedentary behavior are common factors reported to be associated
with serum lipid levels [54,55]. A previous review on the effect of aerobic exercise on serum lipids
recommended that clinicians should rely more on physical activity and less on lipid lowering drugs to
modify lipid variables, thus to reduce the risk of myocardial infractions and CVD [56]. Low physical
activity was found to be associated with dyslipidemia and particularly with high TC and TG in men,
but it was not a significant predictive factor. However, the questionnaire used in our study did not
provide detailed information about the type, timing, and intensity of physical activity. People tend
to start exercising in an attempt to control weight, and various ill-health conditions, which could
explain the loss of association following adjustment for BMI and WC in our study. Specific specialized
questionnaires should be used in future work to provide more detailed information about physical
activity, which would aid in providing more information about the association between physical
activity and dyslipidemia in the Saudi population.
Very short sitting duration (for less than 4 h) was associated with a decreased level of HDL-C in
women in the current study. Short sitting duration might be associated with stress at work. Indeed,
it has been observed in individuals whose career requires high labor work and low sitting hours
and provides low salaries [57]. A previous cross-sectional study on women employees of a retail
company in Japan reported that employees with effort-reward imbalance had a 4.4-fold higher risk of
low HDL-C compared with employees who have balanced effort-reward [57]. This suggests that the
stress in careers or other work-related factors could distort the relationship between physical activity
and dyslipidemia and might explain the observed relationship between low sitting duration and
unfavorable HDL-C profile noted in our study.
Another unexpected finding in this study was that cinnamon drink consumption was associated
with increased risk of dyslipidemia, particularly elevated TC, in women before adjustment for
confounding factors. This was not observed in men probably due to the higher intake of cinnamon
drink in women. In contrast, a previous systematic review and meta-analysis suggested that
cinnamon supplementation has an anti-lipidemic effect especially on plasma cholesterol and TG
in a duration-dependent but not dose-dependent manner [58]. After adjusting for age, BMI, and
WC the association ceased to exist in our study. The inverse association between cinnamon drink
consumption and dyslipidemia observed might be due to the addition of sugar to the drink which is a
common practice among Saudis. Another possible explanation could be due to changes in the diet by
individuals who have been recently diagnosed with dyslipidemia or hyperglycemia. The current study
had a cross-sectional design, which is the main limitation since it did not provide information on the
duration of the recorded dietary pattern. Cinnamon drink is commonly ingested by Saudi individuals
who are diagnosed with dysglycemia due to the common belief that cinnamon lowers blood sugar.
Since dysglycemia occurs more in individuals with dyslipidemia particularly high LDL-C [32], changes
in dietary habits such as increasing consumption of cinnamon drink or fresh vegetables in individuals
diagnosed with dysglycemia or dyslipidemia can result in biased observations regarding the effect
of these food types on serum lipids. In order to obtain a clear picture, future studies should include
information on the duration of the recorded dietary habits, and whether dietary practices have been
changed due to medical advice.
There are limitations to our study. First, its cross-sectional design did not allow for inferences
about cause and effect and can suggest associations only. In addition, collected data was based
on a questionnaire providing self-reported dietary and lifestyle data, hence errors of reporting are
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expected. However, conducting face to face interviews by trained data collectors is believed to minimize
such errors. In addition, our study had a relatively small sample size, but it was enough to detect
several associations.
In spite of the limitation, our study has many points of strength. The first being that bias was
avoided by a random selection of PHC and included volunteers. Secondly, standardized methods for
data collections by well-trained data collectors were used. Moreover, a comprehensive definition was
used to diagnose dyslipidemia, and all collected samples were analyzed in one accredited lab to avoid
variations leading to misclassification.
5. Conclusions
In this studied population, there was a high prevalence of dyslipidemia among men and women
which was found to be associated with increased age, BMI, and WC. Dyslipidemia was associated with
several lifestyle and dietary factors, which was sex-specific. After adjusting for age, BMI, and WC, short
(<6 h), and long (>8 h) sleep duration, and high consumption of Turkish coffee and carbonated drinks
were associated with increased risk of dyslipidemia in men, while high consumption of American
coffee was associated with a decreased risk. However, in women, only increased consumption of fresh
vegetables was associated with an increased risk of dyslipidemia after adjusting for confounding factors.
This highlights the necessity of the adjustment of these modifiable risk factors since individuals
with dyslipidemia are at increased risk of developing CVD. More detailed cohort studies are needed to
reach firmer conclusions and lead to prevention recommendations. Nevertheless, results from this
study provide useful information for the planning of future preventive actions against CVD.
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